A Public Health Perspective on Sleep Health Prioritizing.

Published Date: 27 Apr 2023

The field is reaching a point where sleep health will become a top priority for public health as a result of the great strides made in the field over the past year, as well as the effects of the COVID-19 pandemic and lingering care challenges.

Read Full News

Latest News

Ionis Pharma Prices First FDA-approved Treatment for Alexander Disease At $285,000 Per Dose

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

New Migraine Prevention Guidelines Released

Updated migraine prevention guidelines recommend preventive treatment for patients with ≥ 4 migraine days per month and incorporate CGRP-targeted therapies into individualized treatment selection.

Novartis Pauses Trials Of Experimental Cell Therapy After Three Deaths

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral Palsy Linked to Gaps in Gynecologic Care

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

Borderline Personality: Evidence Has Evolved. Care Hasn’t

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

New Stroke Rehab Guideline Calls for Earlier, Broader Care

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Latest News

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

Updated migraine prevention guidelines recommend preventive treatment for patients with ≥ 4 migraine days per month and incorporate CGRP-targeted therapies into individualized treatment selection.

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

News All Time

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Inherited Alzheimer's risk didn't differ between superagers and cognitively average older adults

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Health news and commentary gathered by MedPage Today staff

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

Good things come to those who wait -- and to those who don't wait

FDA Approves Tylenol With Naproxen Combination

First OTC fixed-dose combination product to pair acetaminophen with naproxen sodium

FDA Panel Finds a Peptide It Doesn't Like

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

MRI uncovers neurocysticercosis in a 52-year-old woman

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older

FDA Scientists Raise Questions About Duchenne Drug

Agency says deramiocel did not meet phase III trial endpoints, contrary to reported data

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

News and commentary from the world of neurology and neuroscience

Sugar Rationing in Early Life Linked to Lower Dementia Risk Decades Later

Long-term study looks at what happened when sugar was scarce

FDA Committee Votes Down Duchenne Drug

Agency staff and drug developer disagree on endpoints

Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map

News and commentary from the world of neurology and neuroscience

Fauci Successor Imminent; CDC Expands Outbreak List; Pesticides Linked to ALS

Health news and commentary gathered by MedPage Today staff

FDA Approves First-in-Class Narcolepsy Drug

Oveporexton treats more than symptoms, restores orexin signaling

Medical Journal March 28, 2023

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

3.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

4.

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

5.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

1.

Strategic Concepts in Hematology for Modern Medicine

2.

Is AI The New Radiologist For Breast MRI?

3.

Navigating the Stages of Thyroid Cancer: A Guide for Patients

4.

Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer

5.

Prognostic Patterns of Functional Recovery During Long-Term Cancer Survivorship

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Blood Clotting Disorders Explained

2.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

4.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

5.

Hands-on Workshop: Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

A Public Health Perspective on Sleep Health Prioritizing.

Latest News

Ionis Pharma Prices First FDA-approved Treatment for Alexander Disease At $285,000 Per Dose

New Migraine Prevention Guidelines Released

Novartis Pauses Trials Of Experimental Cell Therapy After Three Deaths

Cerebral Palsy Linked to Gaps in Gynecologic Care

Borderline Personality: Evidence Has Evolved. Care Hasn’t

New Stroke Rehab Guideline Calls for Earlier, Broader Care

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

Latest News

News All Time

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

FDA Approves Tylenol With Naproxen Combination

FDA Panel Finds a Peptide It Doesn't Like

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

First-in-Class Drug for ADHD Wins FDA Approval

FDA Scientists Raise Questions About Duchenne Drug

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

Sugar Rationing in Early Life Linked to Lower Dementia Risk Decades Later

FDA Committee Votes Down Duchenne Drug

Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map

Fauci Successor Imminent; CDC Expands Outbreak List; Pesticides Linked to ALS

FDA Approves First-in-Class Narcolepsy Drug

Recommended News For You

Research has shown that Ga-68 FAPI PET enhances pancreatic cancer detection and staging.

Smartphone App Detects Eye Cancers From Photos

Telemedicine Not Reaching Rural Psychiatric Patients

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Medical Journal March 28, 2023

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

Recommended Articles For You

Exploring the Latest Treatments for Desmoid Tumors

Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025

Tazemetostat: A Promising New Treatment for Cancer

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.